TransCure bioServices SAS
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
TransCure bioServices SAS - overview
Established
2012
Location
-, -, France
Primary Industry
Pharmaceuticals
About
Founded in 2012 and based in Archamps, France, TransCure bioServices SAS is a contract research organization (CRO) that provides in vivo pharmacology preclinical services to pharmaceutical, biotech, start-up, and academic researchers who need solutions for drug profiling. It develops fee-for-service platforms, called the full human immune system mouse (hu-mouse) models for HIV (human immunodeficiency viruses), cancer, infectious diseases & inflammation. In January 2026, Taconic Biosciences, Inc. , a portfolio company of Avista Healthcare Partners, acquired TransCure bioServices SAS from Montpensier Arbevel.
Financial terms were not disclosed.
Current Investors
Taconic Biosciences, Inc., Montpensier Arbevel
Primary Industry
Pharmaceuticals
Sub Industries
Oncology/Cancer Treatment, Pharmaceutical Research & Development
Website
www.transcurebioservices.com
Company Stage
Add-on
Total Amount Raised
Subscriber access only
TransCure bioServices SAS - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Add-on, Trade Sale | Completed | TransCure bioServices SAS | - |
Displaying 1 - 1 of 1
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.